Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) versus Placebo

Study Status: 
Active
Study Description: 

The purpose of this study is to find out if a new drug called Solanezumab can help people with Alzheimer's disease (AD). We also want to find out if Solanezumab is safe to take without causing too many side effects. In AD, amyloid fragments gather and form hard plaques. Doctors think that amyloid can cause symptoms such as memory loss and confusion. We hope that Solanezumab can reduce the amount of amyloid in the brain.

 

Who is eligible?

Please see attached.

Study Coordinator(s): 

Sehily Jaimes

Tel:  617-643-5200

AttachmentSize
LZAX Web Blurb.doc30 KB